News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,888 Results
Type
Article (41906)
Company Profile (435)
Press Release (664547)
Section
Business (208549)
Career Advice (2016)
Deals (35984)
Drug Delivery (97)
Drug Development (83441)
Employer Resources (170)
FDA (16371)
Job Trends (15063)
News (352397)
Policy (33013)
Tag
Academia (2620)
Alliances (50818)
Alzheimer's disease (1346)
Approvals (16328)
Artificial intelligence (200)
Bankruptcy (364)
Best Places to Work (11830)
Biotechnology (329)
Breast cancer (221)
Cancer (1662)
Cardiovascular disease (132)
Career advice (1681)
CAR-T (118)
Cell therapy (347)
Clinical research (66870)
Collaboration (655)
Compensation (339)
COVID-19 (2616)
C-suite (152)
Data (1547)
Diabetes (206)
Diagnostics (6299)
Earnings (86405)
Employer resources (147)
Events (114118)
Executive appointments (548)
FDA (17219)
Funding (588)
Gene therapy (246)
GLP-1 (675)
Government (4439)
Healthcare (19080)
Infectious disease (2719)
Inflammatory bowel disease (121)
Interviews (309)
IPO (16708)
Job creations (3697)
Job search strategy (1431)
Layoffs (459)
Legal (7955)
Lung cancer (248)
Manufacturing (234)
Medical device (13395)
Medtech (13400)
Mergers & acquisitions (19588)
Metabolic disorders (555)
Neuroscience (1762)
NextGen: Class of 2025 (6749)
Non-profit (4544)
Northern California (1975)
Obesity (315)
Opinion (209)
Patents (141)
People (58118)
Phase I (21005)
Phase II (29519)
Phase III (21808)
Pipeline (666)
Postmarket research (2600)
Preclinical (8956)
Radiopharmaceuticals (256)
Rare diseases (324)
Real estate (6002)
Regulatory (22300)
Research institute (2406)
Resumes & cover letters (351)
Southern California (1728)
Startups (3753)
United States (18007)
Vaccines (619)
Weight loss (220)
Date
Today (140)
Last 7 days (636)
Last 30 days (2859)
Last 365 days (35763)
2025 (3165)
2024 (36299)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54923)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (733)
Arizona (215)
Asia (38854)
Australia (6466)
California (4593)
Canada (1637)
China (380)
Colorado (209)
Connecticut (223)
Europe (84768)
Florida (653)
Georgia (158)
Illinois (456)
Indiana (253)
Maryland (725)
Massachusetts (3599)
Michigan (193)
Minnesota (332)
New Jersey (1293)
New York (1304)
North Carolina (868)
Northern California (1975)
Ohio (166)
Pennsylvania (1059)
South America (1107)
Southern California (1728)
Texas (668)
Utah (138)
Washington State (463)
706,888 Results for "tizona therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
Tizona Therapeutics, Inc. announced first-in-human Phase 1b clinical data of TTX-080, a novel, first-in-class, antibody targeting HLA-G, in patients with metastatic colorectal cancer and locally advanced/metastatic head and neck squamous cell carcinoma.
May 23, 2024
·
5 min read
Press Releases
Tizona Therapeutics Announces Expansion of Phase 1b Clinical Trial to Evaluate TTX-080 in Combination with EGFR Inhibitor Cetuximab and Chemotherapy in Advanced Colorectal Cancer
October 31, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting
February 4, 2025
·
7 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Roche purchases shares in tender offer for Poseida Therapeutics, Inc.
January 8, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
Press Releases
Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray
January 27, 2025
·
2 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
1 of 70,689
Next
